Flow Neuroscience announced that the FDA approved its Flow at-home brain stimulation device for treating major depressive disorder (MDD).

The FDA has approved a device that aims to treat depression by sending electric current into a part of the brain known to ...

For decades, neurology treated the brain like a black box, nudging it with drugs and hoping symptoms would ease. Now ...

Psilocybin, the psychoactive compound in so-called magic mushrooms, is emerging as one of the most intriguing tools in modern ...

Patients with depression are at higher risk of cardiovascular disease, and a new study suggests that stress may help explain ...

Bipolar disorder (BD) is a psychiatric disorder characterized by extreme mood changes. Individuals diagnosed with BD ...

The FDA recently cleared this device for sale in the U.S. Research shows it can improve moderate to severe depression ...

The FDA has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to ...

New findings suggest that a protein known as Reelin could play a role in treating both “leaky gut” and severe depression. Could an injectable protein someday help address both “leaky gut” and severe ...

O. Rose Broderick reports on the health policies and technologies that govern people with disabilities’ lives. Before coming to STAT, she worked at WNYC’s Radiolab and Scientific American, and her ...

A new study into the biological mechanisms underlying depression may have upended the widely held belief that the condition is associated with inflammation. It found that suppression of the brain’s ...

Depression and anxiety may heighten cardiovascular disease risk through chronic stress pathways in the brain and body.